Browsing by Author "Ozkan, Metin"
Now showing items 1-12 of 12
-
Anxiety, Depression and Quality of Sleep in Cancer Patients
Tel, Hatice; Tel, Havva; Er, Oezlem; Ozkan, Metin (UNIVERSITATSVERLAG ULM GMBH, 2008)The anxiety, depression and sleep quality of cancer patients (107) who were admitted to a oncology hospital's medical oncology ward were investigated. Data were collected using a personel information form, the hospital ... -
Clinicopathological Characteristics and Prognosis of Patients According To Recurrence Time After Radical Nephrectomy for Localized Renal Cell Carcinoma: A Multicenter Study of Anatolian Society of Medical Oncology (ASMO)
Bozkurt, Oktay; Inanc, Mevlude; Hacibekiroglu, Ilhan; Esbah, Onur; Seker, Metin; Ulas, Arife; Aydin, Kubra; Uysal, Mukremin; Kucukoner, Mehmet; Uncu, Dogan; Ciltas, Aydin; Unal, Olcun Umit; Durnali, Ayse; Demirci, Umut; Berk, Veli; Tonyali, Onder; Oksuzoglu, Berna; Karaca, Halit; Ozkan, Metin (INT INST ANTICANCER RESEARCH, 2014)Aim: We investigated the clinicopathological features in patients with recurrent RCC within 5 years or more than 5 years after nephrectomy and determined predictors of survival and response treatment after recurrence. ... -
Comparison of survival with somatostatin analog and chemotherapy and prognostic factors for treatment in 165 advanced neuroendocrine tumor patients with Ki-67 20% or less
Ozaslan, Ersin; Karaca, Halit; Koca, Sinan; Sevinc, Alper; Hacioglu, Bekir; Ozkan, Metin; Ozcelik, Melike; Duran, Ayse O.; Hacibekiroglu, Ilhan; Yildiz, Yasar; Tanriverdi, Ozgur; Menekse, Serkan; Aksoy, Asude; Bozkurt, Oktay; Urvay, Semiha; Uysal, Mukremin; Demir, Hacer; Ciltas, Aydin; Dane, Faysal (LIPPINCOTT WILLIAMS & WILKINS, 2017)The objectives of this study were to compare progression-free survival (PFS) with somatostatin analog (SSA) versus chemotherapy (CTx) in first-line therapy and to determine the patient group in which these treatments were ... -
The effect of the gastrectomy on survival in patients with metastatic gastric cancer: a study of ASMO
Yazici, Ozan; Ozdemir, Nuriye; Duran, Ayse Ocak; Menekse, Serkan; Ali, Mehmet; Sendur, Nahit; Karaca, Halit; Goksel, Gamze; Arpaci, Erkan; Hacibekiroglu, Ilhan; Bilgetekin, Irem; Kacan, Turgut; Ozkan, Metin; Aksoy, Sercan; Aksoy, Asude; Cokmert, Suna; Uysal, Mukremin; Elkiran, Emin Tamer; Cicin, Irfan; Buyukberber, Suleyman; Zengin, Nurullah (FUTURE MEDICINE LTD, 2016)Aim: To investigate the role of surgical resection of primary tumor on overall survival (OS) in advanced gastric cancer patients at the time of diagnosis. Patients & methods: The survival rates of metastatic gastric cancer ... -
Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer
Ozaslan, Ersin; Topaloglu, Ulas Serkan; Inanc, Mevlude; Erdem, Umut Gokmen; Demir, Hacer; Arpaci, Erkan; Seker, Mehmet Metin; Karaaga, Mustafa; Kiziltepe, Melih; Eker, Baki; Ozkan, Metin (IMPRIMATUR PUBLICATIONS, 2017)Purpose: To evaluate the efficacy and adverse events with cetuximab plus FOLFOX administered as second- and third-line therapy in metastatic colorectal cancer (mCRC) patients. Methods: IPatients were administered cetuximab ... -
EGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.
Gumus, Mahmut; Geredeli, Caglayan; Ucar, Mahmut; Kaya, Serap; Demir, Hacer; Unal, Olcun Umit; Degirmenci, Mustafa; Dogu, Gamze Gokoz; Turan, Nedim; Yildirim, Nilgun; Basal, Fatma Bugdayci; Arpaci, Erkan; Karaagac, Mustafa; Harputluoglu, Hakan; Turk, Had Mehmet; Dane, Faysal; Ozkan, Metin (AMER SOC CLINICAL ONCOLOGY, 2017)… -
Extrapulmonary involvement in patients with sarcoidosis in Turkey
Okumus, Gulfer; Musellim, Benan; Cetinkaya, Erdogan; Turker, Hatice; Uzaslan, Esra; Yenturk, Esin; Uzun, Oguz; Saglam, Leyla; Kumbasar, Ozlem Ozdemir; Celik, Gokhan; Annakkaya, Ali Nihat; Altiay, Gundeniz; Tabak, Levent; Sakar, Aysin; Kiter, Goksel; Erturan, Serdar; Turktas, Haluk; Yalniz, Enver; Akkoclu, Atilla; Ogus, Candan; Dogan, Omer Tamer; Ozkan, Metin; Aktogu, Serir; Uzel, Isil; Ongen, Gul (WILEY-BLACKWELL, 2011)Background and objective: Extrapulmonary sarcoidosis is common, and is almost always associated with concomitant thoracic involvement. Extrapulmonary manifestations vary on the basis of gender, age at presentation and ... -
Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology
Arpaci, Erkan; Yetisyigit, Tarkan; Seker, Metin; Uncu, Dogan; Uyeturk, Ummugul; Oksuzoglu, Berna; Demirci, Umut; Coskun, Ugur; Kucukoner, Mehmet; Isikdogan, Abdurrahman; Inanc, Mevlude; Alkis, Necati; Ozkan, Metin (HUMANA PRESS INC, 2013)The aim of this study was to evaluate prognostic factors, survival rate and the efficacy of the treatment modalities used in patients with Ewing sarcoma family of tumors (ESFT). Data of patients with ESFTs followed up at ... -
The role of the gastrectomy on survival in metastatic gastric cancer patients: A multicenter study of Anatolian Society of Medical Oncology (ASMO)
Yazici, Ozan; Ozdemir, Nuriye; Duran, Ayse Ocak; Menekse, Serkan; Sendur, Mehmet Ali Nahit; Karaca, Halit; Goksel, Gamze; Arpaci, Erkan; Eren, Tulay; Hacibekiroglu, Ilhan; Bilgetekin, Irem; Kacan, Turgut; Ozkan, Metin; Aksoy, Sercan; Aksoy, Asude; Zengin, Nurullah (AMER SOC CLINICAL ONCOLOGY, 2015)… -
Summary of Consensus Report on Preoperative Evaluation
Ozkan, Metin; Kirkil, Gamze; Dilektasli, Asli Gorek; Sogut, Ayhan; Sertogullarindan, Bunyamin; Cetinkaya, Erdogan; Coskun, Funda; Ulubay, Gaye; Yuksel, Hasan; Sezer, Murat; Ozbudak, Omer; Ulasli, Sevinc Sarinc; Arslan, Sulhattin; Kovan, Tezay (BILIMSEL TIP PUBLISHING HOUSE, 2015)… -
XELOX Plus Bevacizumab vs. FOLFIRI Plus Bevacizumab Treatment for First-line Chemotherapy in Metastatic Colon Cancer: a Retrospective Study of the Anatolian Society of Medical Oncology
Duran, Ayse Ocak; Karaca, Halit; Besiroglu, Mehmet; Bayoglu, Ibrahim Vedat; Menekse, Serkan; Yapici, Heves Surmeli; Yazilitas, Dogan; Bahceci, Aykut; Uysal, Mukremin; Sevinc, Alper; Hacibekiroglu, Ilhan; Aksoy, Asude; Tanriverdi, Ozgur; Arpaci, Erkan; Inanc, Mevlude; Dane, Faysal; Ozkan, Metin (ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 2014)Background: XELOX plus bevacizumab (XELOX-Bev) and FOLFIRI plus Bevacizumab (FOLFIRI - Bev) treatments are an effective strategies patients with metastatic colorectal cancer (mCRC). The aim of this study was to compare ...